Please see the below release from Avrobio.
Interested in participating? AVRO-RD-01-201 is a Phase2, open-label multinational clinical trial designed to evaluate the safety and efficacy of AVR-RD-01, an ex vivo, lentiviral vector-mediated gene therapy in individuals with Fabry disease.
The AVRO trial is being conducted around the world and in sites in Canada. If you are interested in participating please send us a message at the Canadian Fabry Association or reach out directly to Dr. Aneal Khan at the Children’s Alberta Hospital at : email@example.com or Shelly Jelinski at Shelly.Jelinski@albertahealthservices.ca for more information. Please call Shelly at 403-955-7874
Study information website: https://avrobiofabrytrial.com/
Subscribe error, please review your email address.Close
You're now subscribed, thank you!Close
There was a problem with your submission. Please check the field(s) with red label below.Close
Your message has been sent. We'll get back to you soon!Close